378800 샤페론

기본 정보

• 섹터: KOSDAQ:제조
• 시가총액: 234억원 (2026-06-30 기준)
• 첫 등장: 2026-06-15 (누적 2일)
• 태그: 매크로/IT소프트웨어 · 매크로/바이오헬스 · 항체 · 염증치료제 · 아토피 · 알츠하이머 · 합성신약 · AI신약 · 나노맙
• 네이버 금융: 🔗

기업개요

• 동사는 2008년 설립된 염증복합체 조절 기술 기반의 신약 연구개발 전문기업임.
• 세계 최초 GPCR19 표적 염증복합체 억제제 플랫폼과 나노맙 항체 개발 플랫폼을 보유하고 있으며, 신약 후보물질을 기술이전하는 것이 주요 사업모델임.
• 아토피 치료제 미국 임상 2b상을 진행 중이며, 알츠하이머 치매 치료제 국내 임상 1상 완료, AI 기반 신약 개발 플랫폼 AIDEN을 구축하여 신약 개발을 가속화하고 있음.

출처: 네이버증권 종목분석 (WiseReport)

일자별 등장 (최신 위, 누적)

일자	전일 종가	종가	등락률	시간외	vol	색깔	smart	외	연	금투	투	개	그외
2026-08-14	524	514	🔵 -1.91%	—	×1.6	🔻 개인	-0.6억	-0.6	+0.0	+0.0	+0.0	+0.7	-0.1
2026-08-13	614	524	🔵 -14.66%	—	×8.0	🔻 개인	-6.0억	-6.0	+0.0	-0.0	+0.0	+5.9	+0.2
2026-08-12	473	614	🔴 +29.81%	—	×3.6	🟢 외인	+1.2억	+1.2	+0.0	+0.0	+0.0	-1.2	-0.0
2026-08-11	467	473	🔴 +1.28%	—	×0.7	🟢 외인	+0.7억	+0.7	+0.0	+0.0	+0.0	-0.7	+0.0
2026-08-10	475	467	🔵 -1.68%	—	×0.6	🟢 외인	+0.7억	+0.7	+0.0	+0.0	+0.0	-0.7	+0.0
2026-08-07	469	475	🔴 +1.28%	—	×0.7	🟢 외인	+0.5억	+0.5	+0.0	+0.0	+0.0	-0.5	+0.0
2026-08-06	491	469	🔵 -4.48%	—	×0.6	🔻 개인	-0.0억	-0.0	+0.0	+0.0	+0.0	+0.0	+0.0
2026-08-05	491	491	⚪ +0.00%	—	×5.6	🔻 개인	-1.6억	-1.6	+0.0	+0.0	+0.0	+2.3	-0.6
2026-08-04	437	491	🔴 +12.36%	—	×1.7	🟢 외인	+1.4억	+1.4	+0.0	+0.0	+0.0	-1.4	+0.0
2026-08-03	419	437	🔴 +4.30%	—	×0.8	🟢 외인	+0.7억	+0.7	+0.0	+0.0	+0.0	-0.7	+0.0
2026-07-31	415	419	🔴 +0.96%	—	×1.3	🔻 개인	-0.5억	-0.5	+0.0	+0.0	+0.0	+0.5	+0.0
2026-07-30	409	415	🔴 +1.47%	—	×0.4	🟢 외인	+0.2억	+0.2	+0.0	+0.0	+0.0	-0.2	+0.0
2026-07-29	464	409	🔵 -11.85%	—	×1.1	🟢 외인	+0.6억	+0.6	+0.0	+0.0	+0.0	-0.5	-0.0
2026-07-28	496	464	🔵 -6.45%	—	×0.8	🟢 외인	+0.4억	+0.4	+0.0	+0.0	+0.0	-0.4	+0.0
2026-07-27	520	496	🔵 -4.62%	—	×1.1	🔻 개인	-1.1억	-1.1	+0.0	+0.0	+0.0	+1.1	+0.0
2026-07-24	526	520	🔵 -1.14%	—	×1.3	🟢 외인	+0.6억	+0.6	+0.0	+0.0	+0.0	-0.6	+0.0
2026-07-23	521	526	🔴 +0.96%	—	×0.4	🟢 외인	+0.3억	+0.3	+0.0	+0.0	+0.0	-0.3	+0.0
2026-07-22	518	521	🔴 +0.58%	—	×0.4	🟢 외인	+0.8억	+0.8	+0.0	+0.0	+0.0	-0.9	+0.0
2026-07-21	514	518	🔴 +0.78%	—	×1.0	🔻 개인	-1.1억	-1.1	+0.0	+0.0	+0.0	+1.1	+0.0
2026-07-20	535	514	🔵 -3.93%	—	×0.4	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.0	+0.1	+0.0
2026-07-16	538	535	🔵 -0.56%	—	×0.2	🟢 외인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0	-0.0
2026-07-15	511	538	🔴 +5.28%	—	×0.2	🟢 외인	+1.1억	+1.1	+0.0	+0.0	+0.0	-1.1	+0.0
2026-07-14	523	511	🔵 -2.29%	—	×0.3	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.0	+0.2	+0.0
2026-07-13	557	523	🔵 -6.10%	—	×0.3	🟢 외인	+1.0억	+1.0	+0.0	+0.0	+0.0	-1.0	+0.0
2026-07-10	519	557	🔴 +7.32%	—	×0.7	🟢 외인	+2.2억	+2.2	+0.0	-0.0	+0.0	-0.9	-1.3
2026-07-09	503	519	🔴 +3.18%	—	×0.3	🟢 외인	+0.3억	+0.3	+0.0	+0.0	+0.0	-0.3	-0.0
2026-07-08	526	503	🔵 -4.37%	—	×0.4	🟢 외인	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.1	+0.0
2026-07-07	537	526	🔵 -2.05%	—	×0.7	🔻 개인	-0.5억	-0.5	+0.0	+0.0	+0.0	+0.5	+0.1
2026-07-06	604	537	🔵 -11.09%	—	×0.5	🔻 개인	-1.5억	-1.5	+0.0	+0.0	+0.0	+1.5	+0.0
2026-07-03	530	604	🔴 +13.96%	—	×0.8	⚫ 그외	+0.1억	+0.1	+0.0	-0.0	+0.0	-0.2	+0.1
2026-07-02	543	530	🔵 -2.39%	—	×0.7	🟢 외인	+0.4억	+0.4	+0.0	+0.0	+0.0	-0.2	-0.1
2026-07-01	508	543	🔴 +6.89%	—	×1.1	🟢 외인	+2.9억	+2.9	+0.0	+0.0	+0.0	-0.5	-2.4
2026-06-30	612	508	🔵 -16.99%	—	×1.3	🔻 개인	+1.0억	+1.0	+0.0	+0.0	+0.0	+1.3	-2.3
2026-06-29	568	612	🔴 +7.75%	—	×1.2	🟢 외인	+3.6억	+3.6	+0.0	+0.0	+0.0	-2.5	-1.1
2026-06-26	759	568	🔵 -25.16%	—	×4.8	🟢 외인	+1.0억	+1.0	+0.0	+0.0	+0.0	-0.8	-0.2
2026-06-25	1,084	759	🔵 -29.98%	—	×3.9	🟢 외인	+5.4억	+5.4	+0.0	+0.0	+0.0	-6.2	+0.8
2026-06-24	1,075	1,084	🔴 +0.84%	—	×0.3	🟢 외인	+0.2억	+0.2	+0.0	+0.0	+0.0	-0.2	+0.0
2026-06-23	1,120	1,075	🔵 -4.02%	—	×0.5	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.1	+0.0
2026-06-22	1,295	1,120	🔵 -13.51%	—	×1.0	🔻 개인	-2.1억	-2.1	+0.0	+0.0	+2.1	-0.0
2026-06-19	1,200	1,295	🔴 +7.92%	—	×3.6	🔻 개인	-1.1억	-1.1	+0.0	+0.0	+1.3	-0.2
2026-06-18	1,280	1,200	🔵 -6.25%	—	×0.6	🔻 개인	-1.0억	-1.0	+0.0	+0.0	+1.1	-0.0
2026-06-17	1,147	1,280	🔴 +11.60%	—	×2.1	🔻 개인	-0.9억	-0.9	+0.0	+0.0	+0.7	+0.2
2026-06-16	1,300	1,147	🔵 -11.77%	—	×1.2	🔻 개인	-1.9억	-1.9	+0.0	+0.0	+1.7	+0.1
2026-06-15	1,115	1,300	🔴 +16.59%	—	×13.1	🔻 개인	-4.6억	-4.6	+0.0	+0.0	+4.7	-0.2
2026-06-12	1,075	1,115	🔴 +3.72%	—	×0.9	🔻 개인	-1.2억	-1.2	+0.0	+0.0	+1.1	+0.1
2026-06-11	1,039	1,075	🔴 +3.46%	—	×0.5	⚫ 그외	-0.0억	-0.0	+0.0	+0.0	+0.0	+0.0
2026-06-10	1,063	1,039	🔵 -2.26%	—	×0.4	🔻 개인	-0.3억	-0.3	+0.0	+0.0	+0.3	+0.0
2026-06-09	972	1,063	🔴 +9.36%	—	×1.4	🔻 개인	-0.3억	-0.3	+0.0	-0.0	+0.4	-0.1
2026-06-08	1,090	972	🔵 -10.83%	—	×0.9	🔻 개인	-0.6억	-0.6	+0.0	+0.0	+0.6	+0.0
2026-06-05	1,118	1,090	🔵 -2.50%	—	×0.5	🟢 외인	+1.2억	+1.2	+0.0	+0.0	-1.2	-0.0
2026-06-04	1,139	1,118	🔵 -1.84%	—	×0.3	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.1	+0.0
2026-06-02	1,143	1,139	🔵 -0.35%	—	×0.7	🟢 외인	+1.1억	+1.1	+0.0	+0.0	-1.1	+0.0
2026-06-01	1,224	1,143	🔵 -6.62%	—	×0.8	🟢 외인	+0.3억	+0.3	+0.0	+0.0	-0.3	+0.0
2026-05-29	1,190	1,224	🔴 +2.86%	—	×0.9	🟢 외인	+0.2억	+0.2	+0.0	+0.0	-0.2	-0.0
2026-05-28	1,237	1,190	🔵 -3.80%	—	×0.6	🟢 외인	+0.8억	+0.8	+0.0	-0.0	-0.7	-0.1
2026-05-27	1,292	1,237	🔵 -4.26%	—	×0.7	🟢 외인	+0.2억	+0.2	+0.0	+0.0	-0.2	-0.0
2026-05-26	1,355	1,292	🔵 -4.65%	—	×0.7	🔻 개인	-2.6억	-2.6	+0.0	+0.0	+2.7	-0.0
2026-05-22	1,290	1,355	🔴 +5.04%	—	×0.8	🟢 외인	+2.9억	+2.9	+0.0	-0.0	-2.9	+0.0

일자별 사유 (최신 위)

2026-08-12

• 사유: —
• 섹터 컨텍스트: KOSDAQ:제조 (smart -1,078억)
• 매크로 원인: 동전주·시총미달 36곳 관리종목 지정 이슈로 제약바이오 소형주 급등락, 씨젠은 자사주 소각·실적 호조 겹호재 (보통)

2026-08-04

• 사유: —
• 섹터 컨텍스트: KOSDAQ:제조 (smart -1,616억)
• 매크로 원인: 코스닥 6%대 급반등 속 경영진 자사주 매입·임상데이터·기술이전 호재로 바이오 전반 강세 (보통)

2026-07-03

• 사유: —
• 섹터 컨텍스트: KOSDAQ:제조 (smart -512억)
• 매크로 원인: 원인 미확인 (낮음)

2026-06-17

• 사유: —
• 섹터 컨텍스트: KOSDAQ:제조 (smart +204억)
• 매크로 원인: 바이오 USA 개막발 기술이전 기대 + FDA·임상 호재로 소외됐던 제약바이오 일제 반등 (보통)

2026-06-15

• 사유: —
• 섹터 컨텍스트: KOSDAQ:제조 (smart -8,112억)
• 매크로 원인: 복지장관 하반기 탈모치료 건보 적용 추진 소식에 탈모 관련주 급등, 일부 기술이전·신약 모멘텀 (보통)